
New survey reveals primary gastrointestinal complaint for people living with HIV/AIDS
SAN FRANCISCO, Calif. — Napo Pharmaceuticals, Inc. (Napo), a human health company developing and commercializing novel gastrointestinal prescription products from plants used traditionally in rainforest areas, and a wholly-owned subsidiary of Jaguar Health, Inc. (NASDAQ: JAGX) (Jaguar), announced today the results of a survey of 271 U.S. board certified gastroenterologists, which indicate that the number…